Search Results - "Ouvrard‐Pascaud, Antoine"
-
1
Short‐ and long‐term administration of the non‐steroidal mineralocorticoid receptor antagonist finerenone opposes metabolic syndrome‐related cardio‐renal dysfunction
Published in Diabetes, obesity & metabolism (01-10-2018)“…Aim To determine whether non‐steroidal mineralocorticoid receptor (MR) antagonists oppose metabolic syndrome‐related end‐organ, i.e. cardiac, damage. Materials…”
Get full text
Journal Article -
2
Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B‐deficient mice
Published in The FASEB journal (01-08-2014)“…The protein tyrosine phosphatase 1B (PTP1B) modulates tyrosine kinase receptors, among which is the vascular endothelial growth factor receptor type 2…”
Get full text
Journal Article -
3
Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models
Published in Scientific reports (28-01-2021)“…Neutrophil gelatinase-associated lipocalin (NGAL) is involved in cardiovascular and renal diseases. Gene inactivation of NGAL blunts the pathophysiological…”
Get full text
Journal Article -
4
Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice
Published in ESC Heart Failure (01-06-2021)“…Aims In post‐menopausal women, incidence of heart failure with preserved ejection fraction is higher than in men. Hormonal replacement therapies did not…”
Get full text
Journal Article -
5
Transient heart rate reduction improves acute decompensated heart failure‐induced left ventricular and coronary dysfunction
Published in ESC Heart Failure (01-04-2021)“…Aims Acute decompensated heart failure (ADHF), a live‐threatening complication of heart failure (HF), associates a further decrease of the already by…”
Get full text
Journal Article -
6
Aldosterone promotes cardiac endothelial cell proliferation in vivo
Published in Journal of the American Heart Association (06-01-2015)“…Experimentally, aldosterone in association with NaCl induces cardiac fibrosis, oxidative stress, and inflammation through mineralocorticoid receptor…”
Get full text
Journal Article -
7
Vascular Smooth Muscle Mineralocorticoid Receptor Contributes to Coronary and Left Ventricular Dysfunction After Myocardial Infarction
Published in Hypertension (Dallas, Tex. 1979) (01-04-2016)“…Mineralocorticoid receptor (MR) antagonists slow down the progression of heart failure after myocardial infarction (MI), but the cell-specific role of MR in…”
Get full text
Journal Article -
8
Smooth Muscle Cell Mineralocorticoid Receptors Are Mandatory for Aldosterone–Salt to Induce Vascular Stiffness
Published in Hypertension (Dallas, Tex. 1979) (01-03-2014)“…Arterial stiffness is recognized as a risk factor for many cardiovascular diseases. Aldosterone via its binding to and activation of the mineralocorticoid…”
Get full text
Journal Article -
9
Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition
Published in Scientific reports (03-07-2019)“…Although optimal therapy for myocardial infarction includes reperfusion to restore blood flow to the ischemic region, ischemia/reperfusion (IR) also initiates…”
Get full text
Journal Article -
10
Mineralocorticoid receptor antagonism improves diastolic dysfunction in chronic kidney disease in mice
Published in Journal of molecular and cellular cardiology (01-08-2018)“…Managing the cardiovascular complications of renal failure is a major therapeutic challenge in clinical practice. Mineralocorticoid Receptor (MR) blockade is a…”
Get full text
Journal Article -
11
Aldosterone-Specific Activation of Cardiomyocyte Mineralocorticoid Receptor In Vivo
Published in Hypertension (Dallas, Tex. 1979) (01-02-2013)“…Inappropriate mineralocorticoid receptor (MR) activation is involved in cardiac diseases. Whether and how aldosterone is involved in the deleterious effects of…”
Get full text
Journal Article -
12
BPIFB4 and its longevity-associated haplotype protect from cardiac ischemia in humans and mice
Published in Cell death & disease (15-08-2023)“…Long-living individuals (LLIs) escape age-related cardiovascular complications until the very last stage of life. Previous studies have shown that a…”
Get full text
Journal Article -
13
Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B
Published in Journal of molecular and cellular cardiology (01-06-2012)“…Abstract Protein tyrosine phosphatase 1B (PTP1B) regulates tyrosine kinase receptor-mediated responses, and especially negatively influences insulin…”
Get full text
Journal Article -
14
Coronary endothelial dysfunction after cardiomyocyte-specific mineralocorticoid receptor overexpression
Published in American journal of physiology. Heart and circulatory physiology (01-06-2011)“…The deleterious effects of aldosterone excess demonstrated in cardiovascular diseases might be linked in part to coronary vascular dysfunction. However,…”
Get more information
Journal Article -
15
Conditional Transgenic Mice for Studying the Role of the Glucocorticoid Receptor in the Renal Collecting Duct
Published in Endocrinology (Philadelphia) (01-05-2009)“…The mineralocorticoid receptor (MR) is a major regulator of renal sodium reabsorption and body fluid homeostasis. However, little is known about glucocorticoid…”
Get full text
Journal Article -
16
Reversible Cardiac Fibrosis and Heart Failure Induced by Conditional Expression of an Antisense mRNA of the Mineralocorticoid Receptor in Cardiomyocytes
Published in Proceedings of the National Academy of Sciences - PNAS (14-05-2002)“…Cardiac failure is a common feature in the evolution of cardiac disease. Among the determinants of cardiac failure, the reninangiotensin-aldosterone system has…”
Get full text
Journal Article -
17
Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone
Published in Journal of diabetes and its complications (01-05-2024)“…•Diabetic kidney disease (DKD) develops in nearly 40% of patients with diabetes, and is a leading cause of end-stage renal disease…”
Get full text
Journal Article -
18
Aldosterone Target NGAL (Neutrophil Gelatinase–Associated Lipocalin) Is Involved in Cardiac Remodeling After Myocardial Infarction Through NFκB Pathway
Published in Hypertension (Dallas, Tex. 1979) (01-12-2017)“…Myocardial infarction (MI) is accompanied by cardiac fibrosis, which contributes to cardiac dysfunction. Mineralocorticoid receptor (MR) antagonists have…”
Get full text
Journal Article -
19
Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure
Published in Cardiovascular research (31-03-2023)“…Lymphatics are essential for cardiac health, and insufficient lymphatic expansion (lymphangiogenesis) contributes to development of heart failure (HF) after…”
Get full text
Journal Article -
20
Finerenone improves HFpEF in obese female mice and slows down its acceleration after a postmenopausal transition
Published in Archives of cardiovascular diseases (01-06-2024)“…Metabolic syndrome (MetS) and its related comorbidities significantly elevate the risk of heart failure with preserved ejection fraction (HFpEF), especially…”
Get full text
Journal Article